Chemotherapy in Advanced Hepatocellular Cancer
Sort by:
ASCO GI 2023 Conference Coverage
ASCO GI 2023 NRG/RTOG 1112 Randomized Phase 3 Study: Sorafenib vs. SBRT Followed by Sorafenib in Advanced HCC
FEATURING
Laura Dawson
- 431 views
- February 6, 2023
- 8
ACG 2023 Conference Coverage
ACG 2023 Highlights: HCC Updates - Diagnosis and Management
FEATURING
Robert Wong
- 573 views
- October 26, 2023
- 6
Symposium on Clinical Interventional Oncology (CIO 2018)
M&M: Hard Lessons from the World of IO: Bad Outcomes and Whether They Could Have Been Avoided
FEATURING
Daniel Sze
- 791 views
- October 24, 2018
- 4
Johns Hopkins
Advancements in Systemic Therapy for Advanced HCC: Where Are We Going
FEATURING
Mark Yarchoan
- 643 views
- April 21, 2023
- 3
Total Health
Updates in Radiation Therapy for GI Cancers
FEATURING
Nina Sanford
- 218 views
- March 1, 2023
- 3
Insights from 2024 ASCO® GI Annual Meeting
ASCO® GI 2024 Summary: "HCC Key Studies Including EMERALD-1 & IMbrave 151"
FEATURING
Richard Kim,
Tiago Biachi
- 343 views
- February 1, 2024
- 3
Symposium on Clinical Interventional Oncology (CIO 2018)
Drug-Eluting Embolics
FEATURING
Govindarajan Narayanan
- 755 views
- October 22, 2018
- 2
PrecisCa
What Is the Role for Systemic Chemo vs. IO for the Treatment of Unresectable HCC?
FEATURING
Richard S. Finn
- 135 views
- December 9, 2022
- 2
UCLA Health
Liver Directed Therapy in 2021: What Are the Advances in Transarterial Therapies for HCC? Why Does Y90 Work for PVT?
FEATURING
Siddharth Padia
- 503 views
- May 20, 2021
- 2
University of Colorado Cancer Center
UColorado Updates on Hepatocellular Carcinoma and Biliary Tract Cancers
FEATURING
Lindsey Davis
- 346 views
- April 6, 2022
- 2
Yale Cancer Center
Considerations for 1L Treatment Selection in Advanced HCC: Safety and Efficacy
FEATURING
Stacey Stein
- 146 views
- May 9, 2023
- 1
2023 Johns Hopkins Updates in Gastrointestinal Cancers
Medical Oncology Updates in Unresectable HCC: Where Are We and Where Are We Going?
FEATURING
Daneng Li
- 227 views
- March 7, 2023
- 1
NYU Langone
Common TKI Toxicity Management in 2L HCC Treatment
FEATURING
Jennifer Wu
- 197 views
- May 4, 2023
- 1
OncoAlert
Year in Review: Gastric, Esophageal, & Liver Cancers
FEATURING
Sharlene Gill
- 89 views
- February 22, 2024
- 1
CE Concepts
Immune Checkpoint Inhibition: Utility in HCC and BTC
FEATURING
Katie Kelley
- 89 views
- February 13, 2023
- 1
The France Foundation
Systemic Treatment Landscape for Advanced HCC: Case Discussion - 40 y/o Female With Enlarged, Cirrhotic Appearing Liver
FEATURING
Adam Burgoyne,
Stacey Stein
- 229 views
- October 25, 2023
- 1
Integrity Continuing Education
Mixed HCC-Cholangiocarcinoma: Case Presentation and Panel Discussion
- 22 views
- March 27, 2024
Cedars Sinai
Management of Toxicity and Dose Modification Associated With Cabozantinib in HCC
FEATURING
Jun Gong
- 41 views
- April 19, 2024
The France Foundation
Combining Locoregional and Systemic Therapy for Challenging HCC Cases
FEATURING
Rony Avritscher,
Ahmed O. Kaseb
- 101 views
- October 19, 2023
CE Concepts
Pathophysiologic Foundations in HCC/BTC: Immune System as a Therapeutic Target
FEATURING
James Harding
- 69 views
- February 13, 2023
Yale Cancer Center
Updates in Combination Therapy for HCC
FEATURING
Stacey Stein
- 202 views
- April 24, 2024
Total Health
Updates in the Management of Advanced HCC
FEATURING
Thatcher Heumann
- 149 views
- March 8, 2023
Recommended Topics:
All Topics:
Chemoembolization
Chemotherapy
Chemotherapy in Advanced Hepatocellular Cancer
Cholangiocarcinoma
Colorectal Cancer Interventions
Cryoablation for Tumors
Hepatobiliary Tumor Interventions
Irreversible Electroporation
Kidney Tumor Ablation
Liver Directed Therapy in Hepatocellular Cancer
Lung Ablation
MSK Ablation
Pancreatic Cancer Interventions
Percutaneous Nephrostomy
Prostate Cancer Interventions
Radiation Segmentectomy
Radioembolization (Y90)
Radiofrequency Ablation (RFA)
Renal Tumor
Resectable Hepatocellular Cancer